151 related articles for article (PubMed ID: 36938721)
1. High trophinin-associated protein expression predicts good survival in acute myeloid leukemia with normal cytogenetics.
He X; Hu J; Yan C; Liu X; Zhao Y; Yang P; Wang J; Li S; Zhang W; Dong G; Zhang W; Jing H
Cancer Biomark; 2023; 36(3):221-230. PubMed ID: 36938721
[TBL] [Abstract][Full Text] [Related]
2. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of RASGEF1A RNA expression and DNA methylation in cytogenetically normal acute myeloid leukemia.
He X; Zhang W; Fu W; Liu X; Yang P; Wang J; Zhu M; Li S; Zhang W; Zhang X; Dong G; Yan C; Zhao Y; Zeng Z; Jing H
Cancer Biomark; 2023; 36(2):103-116. PubMed ID: 36404533
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X
Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel molecular markers for prognosis estimation of acute myeloid leukemia: over-expression of PDCD7, FIS1 and Ang2 may indicate poor prognosis in pretreatment patients with acute myeloid leukemia.
Tian Y; Huang Z; Wang Z; Yin C; Zhou L; Zhang L; Huang K; Zhou H; Jiang X; Li J; Liao L; Yang M; Meng F
PLoS One; 2014; 9(1):e84150. PubMed ID: 24416201
[TBL] [Abstract][Full Text] [Related]
6. Higher Expression of
Chen C; Chen Z; Chio CL; Zhao Y; Li Y; Liu Z; Jin Z; Wu X; Wei W; Zhao Q; Li Y
Technol Cancer Res Treat; 2021; 20():15330338211052152. PubMed ID: 34738847
[No Abstract] [Full Text] [Related]
7. Trophinin-associated protein expression correlates with shorter survival of patients with glioma: a study based on multiple data fusion analysis.
Sun Y; Liu ZD; Liu RZ; Lian XY; Cheng XB; Jia YL; Liu BF; Gao YZ; Wang X
Mol Biol Rep; 2022 Aug; 49(8):7899-7909. PubMed ID: 35708862
[TBL] [Abstract][Full Text] [Related]
8. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
[TBL] [Abstract][Full Text] [Related]
9. The expression level of Neuronal Calcium Sensor 1 can predict the prognosis of cytogenetically normal AML.
Zhang W; Wang J; Li W; Liu X; Zhao Y; Yang P; Zhu M; Hu K; Li S; Dong G; Yan C; He X; Zhang X; Jing H
Pharmacogenomics J; 2023 Jul; 23(4):89-94. PubMed ID: 36918700
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of PRDM16 expression in acute myeloid leukemia with normal cytogenetics.
Xiang X; Lu Q; Xu X; Cai P; Chen S; Pan J; Zeng Z
Hematology; 2022 Dec; 27(1):499-505. PubMed ID: 35473465
[TBL] [Abstract][Full Text] [Related]
11. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics.
Welsh KJ; Nedelcu E; Wahed A; Bai Y; Dasgupta A; Nguyen A
Ann Clin Lab Sci; 2015; 45(5):515-21. PubMed ID: 26586702
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
14. The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Hu H; Xu L; Chen Y; Luo SJ; Wu YZ; Xu SH; Liu MT; Lin F; Mei Y; Yang Q; Qiang YY; Lin YW; Deng YJ; Lin T; Sha YQ; Huang BJ; Zhang SJ
J Cancer; 2019; 10(4):957-967. PubMed ID: 30854102
[No Abstract] [Full Text] [Related]
15. [Clinical significance of TET2 gene expression in 157 adult acute myeloid leukemia patients with normal cytogenetics].
Zhu Z; Chen J; Yu M; Chen F; Chen Z; Lou J; Tong H; Huang J; Qian W; Meng H; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):802-7. PubMed ID: 25246247
[TBL] [Abstract][Full Text] [Related]
16. High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
Jiao Y; Li Y; Lu Z; Liu Y
Dig Dis Sci; 2019 Jan; 64(1):137-143. PubMed ID: 30284652
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of ACTL10 in Cytogenetic Normal Acute Myeloid Leukemia.
Lai R; Zhang W; He X; Liao X; Liu X; Fu W; Yang P; Wang J; Hu K; Yuan X; Zhang X; Jing H; Liu W
J Cancer; 2020; 11(17):5150-5161. PubMed ID: 32742462
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Ang Q; Wang GJ; Zhu J; Wang WD
Oncotarget; 2016 Jan; 7(3):2585-95. PubMed ID: 26506237
[TBL] [Abstract][Full Text] [Related]
20. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.
Metzeler KH; Maharry K; Radmacher MD; Mrózek K; Margeson D; Becker H; Curfman J; Holland KB; Schwind S; Whitman SP; Wu YZ; Blum W; Powell BL; Carter TH; Wetzler M; Moore JO; Kolitz JE; Baer MR; Carroll AJ; Larson RA; Caligiuri MA; Marcucci G; Bloomfield CD
J Clin Oncol; 2011 Apr; 29(10):1373-81. PubMed ID: 21343549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
